Actor Colin Farrell recently disclosed that his son, James, has Angelman syndrome, one of the driving factors behind Farrell's support for finding a cure for Angelman syndrome and for launching the ...
Colin Farrell has typically been very private about his home life, but now he’s opening up about his experience having a child with Angelman syndrome. Despite being relatively common, affecting 1 in ...
Colin Farrell is opening up about life with his 20-year-old son who has Angelman syndrome. The Irish actor is sharing details of James’ life as they prepare for his 21st birthday, a milestone when ...
Actor Colin Farrell, long an advocate for people with intellectual disabilities, has started a foundation in honor of his son, James, who suffers from Angelman syndrome, a rare neurogenetic disorder.
Mothers are often encouraged to trust their instincts, especially regarding their children's health. But for Tiffany Young, getting others to take her concerns seriously proved challenging when her ...
A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and explores how cutting-edge gene-targeting therapies may offer more ...
Massachusetts General Hospital in Boston announced the opening of its new Angelman Syndrome Clinic — one of only two in the country, according to the release. The clinic was established through a ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Angelman syndrome is a severe, lifelong disorder, similar in its genetic makeup to several other disorders, including autism and ...
Rebecca Burdine knew something was wrong the day her baby girl was born. Sophie was born without a natural sucking reflex, making it nearly impossible to eat. Later, it became clear that she had ...
ION582 showed robust and consistent benefit in communication, cognition and motor function in a broad patient population evaluated with a comprehensive set of assessment tools that collect input from ...
ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...
MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...